Dihydroneopterin aldolase

The enzyme dihydroneopterin aldolase (EC 4.1.2.25) catalyzes the chemical reaction

dihydroneopterin aldolase
oktamer
Identifiers
EC no.4.1.2.25
CAS no.37290-59-8
Databases
IntEnzIntEnz view
BRENDABRENDA entry
ExPASyNiceZyme view
KEGGKEGG entry
MetaCycmetabolic pathway
PRIAMprofile
PDB structuresRCSB PDB PDBe PDBsum
Gene OntologyAmiGO / QuickGO
Search
PMCarticles
PubMedarticles
NCBIproteins
Dihydroneopterin aldolase
crystal structure of 7,8-dihydroneopterin aldolase in complex with guanine
Identifiers
SymbolFolB
PfamPF02152
Pfam clanCL0334
InterProIPR006157
SCOP21b9l / SCOPe / SUPFAM
Available protein structures:
Pfam  structures / ECOD  
PDBRCSB PDB; PDBe; PDBj
PDBsumstructure summary
2-amino-4-hydroxy-6-(D-erythro-1,2,3-trihydroxypropyl)-7,8- dihydropteridine 2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine + glycolaldehyde

This enzyme belongs to the family of lyases, specifically the aldehyde-lyases, which cleave carbon-carbon bonds. The systematic name of this enzyme class is 2-amino-4-hydroxy-6-(D-erythro-1,2,3-trihydroxypropyl)-7,8-dihydropt eridine glycolaldehyde-lyase (2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine-forming). Other names in common use include 2-amino-4-hydroxy-6-(D-erythro-1,2,3-trihydroxypropyl)-7,8-, and dihydropteridine glycolaldehyde-lyase. This enzyme participates in folate biosynthesis.

Structural studies

edit

The structural studies of DHNA have greatly advanced our understanding of its catalytic mechanism, revealing the roles of conserved amino acids in substrate binding and enzymatic activity.[1] Comparative analyses of bacterial DHNA enzymes have uncovered differences in their active site architectures, providing valuable information for the design of species-specific inhibitors.[2] These findings underscore the potential of targeting DHNA as a strategy to disrupt folate biosynthesis in pathogenic bacteria, as demonstrated by the successful inhibition of Staphylococcus aureus and Mycobacterium tuberculosis DHNA in vitro.[3] The absence of DHNA in mammalian cells enhances the selectivity and therapeutic potential of DHNA-specific antimicrobial agents, reducing the likelihood of off-target effects.[4]

Furthermore, the study of bifunctional DHNA-HPPK enzymes, such as those found in Streptococcus pneumoniae, has illuminated the interplay between folate pathway enzymes, offering additional targets for antimicrobial drug development.[5] The development of potent DHNA inhibitors has been a promising step toward novel antibacterial therapies, with some compounds achieving nanomolar-level efficacy in vitro.[3] However, the lack of structural data for Helicobacter pylori DHNA remains a significant gap, emphasizing the need for future research to facilitate the development of narrow-spectrum antibiotics tailored to specific infections.[3]

Structural studies

edit

As of late 2007, 13 structures have been solved for this class of enzymes, with PDB accession codes 1NBU, 1RRI, 1RRW, 1RRY, 1RS2, 1RS4, 1RSD, 1RSI, 1U68, 1Z9W, 2CG8, 2NM2, and 2NM3.

References

edit
  1. ^ Hoh, F.; Yang, Y. S.; Guignard, L.; Padilla, A.; Stern, M. H.; Lhoste, J. M.; van Tilbeurgh, H. (1998-02-15). "Crystal structure of p14TCL1, an oncogene product involved in T-cell prolymphocytic leukemia, reveals a novel beta-barrel topology". Structure (London, England: 1993). 6 (2): 147–155. doi:10.1016/s0969-2126(98)00017-3. ISSN 0969-2126. PMID 9519406.
  2. ^ Mandimika, Tafadzwa; Baykus, Hakan; Vissers, Yvonne; Jeurink, Prescilla; Poortman, Jenneke; Garza, Cutberto; Kuiper, Harry; Peijnenburg, Ad (2007-11-28). "Differential gene expression in intestinal epithelial cells induced by single and mixtures of potato glycoalkaloids". Journal of Agricultural and Food Chemistry. 55 (24): 10055–10066. Bibcode:2007JAFC...5510055M. doi:10.1021/jf0724320. ISSN 0021-8561. PMID 17973450.
  3. ^ a b c Li, James J.; Chao, Hann-Guang; Wang, Haixia; Tino, Joseph A.; Lawrence, R. Michael; Ewing, William R.; Ma, Zhengping; Yan, Mujing; Slusarchyk, Dorothy; Seethala, Ramakrishna; Sun, Huabin; Li, Danshi; Burford, Neil T.; Stoffel, Robert H.; Salyan, Mary Ellen (2004-03-25). "Discovery of a potent and novel motilin agonist". Journal of Medicinal Chemistry. 47 (7): 1704–1708. doi:10.1021/jm0304865. ISSN 0022-2623. PMID 15027861.
  4. ^ Schmidt, P. J.; Yokoyama, M.; McGinniss, M. H.; Levin, R. H. (November 1965). "Erythroid homograft following leukocyte transfusion in a patient with acute leukemia. II. Serologic and immunochemical studies". Blood. 26 (5): 597–609. doi:10.1182/blood.V26.5.597.597. ISSN 0006-4971. PMID 5321111.
  5. ^ Martinez-Sanz, Juan; Yang, Ao; Blouquit, Yves; Duchambon, Patricia; Assairi, Liliane; Craescu, Constantin T. (October 2006). "Binding of human centrin 2 to the centrosomal protein hSfi1". The FEBS Journal. 273 (19): 4504–4515. doi:10.1111/j.1742-4658.2006.05456.x. ISSN 1742-464X. PMID 16956364.

Further reading

edit
edit